Description

The global Albumin Market size was estimated at USD 6,1321 Mn in 2021, growing at a CAGR of 9.8% during the forecast period 2021-2027. Albumins belong to the family of globular proteins. All the proteins present in the albumin family are water-soluble and are moderately soluble in the concentrated salt solutions. When subjected to heat, undergo denaturation. The albumins contribute 50% to 60% of the blood plasma proteins. The most common of them is the serum albumins. The human serum albumin is the most abundant protein in human blood plasma. In March 2016, CSL Behring has announced that the U.S. Food and Drug Administration (FDA) has approved IDELVION [Coagulation Factor IX (Recombinant), Albumin Fusion Protein], its novel, long-acting albumin fusion protein linking recombinant coagulation factor IX with recombinant albumin for the treatment of hemophilia B. The global Albumin Market research report covers exhaustive regional information, that includes North America (the USA and Canada), Europe (Germany, France, Italy, UK, Spain, Russia, Poland, and Rest of Europe), Asia-Pacific (Japan, China, India, Australia & New Zealand, ASEAN (Includes Indonesia, Thailand, Vietnam, Philippines, Malaysia, and Others), South Korea, and Rest of Asia-Pacific), Latin America (Brazil, Mexico, Argentian, Venezuela, and Rest of Latin America), and the Middle East and Africa (Gulf Cooperation Council (GCC) Countries, Israel, South Africa, and Rest of the Middle East and Africa).

ASIA PACIFIC OFFICE

Precision Business Insights, 5th Floor, Mohan’s Elite, Opp : Bharat Petroleum Pump, Khanamet Road, Hitech City, Hyderabad – 500084

EUROPE OFFICE

Precision Business Insights, Kemp House, 152 – 160 City Road, London EC1V 2NX